Literature DB >> 27479821

Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study.

Gro Grimnes1, Lars D Horvei2, Vladimir Tichelaar3, Sigrid K Brækkan2, John-Bjarne Hansen2.   

Abstract

Entities:  

Keywords:  mortality; neutrophil to lymphocyte ratio; venous thromboembolism

Mesh：

Year:  2016        PMID： 27479821      PMCID： PMC5046660          DOI： 10.3324/haematol.2016.145151

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review.

Authors:  Y I G Vladimir Tichelaar; Hanneke J C Kluin-Nelemans; Karina Meijer
Journal:  Thromb Haemost       Date:  2012-03-22       Impact factor: 5.249

2.  Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study.

Authors:  Bríain ó Hartaigh; Jos A Bosch; G Neil Thomas; Janet M Lord; Stefan Pilz; Adrian Loerbroks; Marcus E Kleber; Tanja B Grammer; Joachim E Fischer; Bernhard O Boehm; Winfried März
Journal:  Atherosclerosis       Date:  2012-06-09       Impact factor: 5.162

Review 3.  Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis.

Authors:  Na Wu; Xinghua Chen; Tongjian Cai; Long Wu; Ying Xiang; Mengxuan Zhang; Yafei Li; Zhiyuan Song; Li Zhong
Journal:  Can J Cardiol       Date:  2014-12-09       Impact factor: 5.223

4.  Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.

Authors:  Patrizia Ferroni; Silvia Riondino; Vincenzo Formica; Vittore Cereda; Livia Tosetto; Francesca La Farina; Maria Giovanna Valente; Matteo Vergati; Fiorella Guadagni; Mario Roselli
Journal:  Int J Cancer       Date:  2014-07-23       Impact factor: 7.396

5.  Body height and risk of venous thromboembolism: The Tromsø Study.

Authors:  Sigrid K Braekkan; Knut H Borch; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Journal:  Am J Epidemiol       Date:  2010-04-23       Impact factor: 4.897

6.  Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2).

Authors:  Petter Quist-Paulsen; Inger Anne Naess; Suzanne C Cannegieter; Pål R Romundstad; Sverre C Christiansen; Frits R Rosendaal; Jens Hammerstrøm
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

7.  The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism.

Authors:  Eftal Murat Bakirci; Selim Topcu; Kamuran Kalkan; Ibrahim Halil Tanboga; Abdurrezzak Borekci; Serdar Sevimli; Mahmut Acikel
Journal:  Clin Appl Thromb Hemost       Date:  2013-06-27       Impact factor: 2.389

8.  Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome.

Authors:  Umesh U Tamhane; Sanjay Aneja; Daniel Montgomery; Eva-Kline Rogers; Kim A Eagle; Hitinder S Gurm
Journal:  Am J Cardiol       Date:  2008-06-26       Impact factor: 2.778

9.  Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

Authors:  Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Russell P Tracy; Nena Aleksic; Aaron R Folsom
Journal:  Am J Med       Date:  2002-12-01       Impact factor: 4.965

10.  Innate immunity and coagulation.

Authors:  C T Esmon; J Xu; F Lupu
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824
View more
  8 in total

1.  COVID-19 infection-associated coagulopathy: Pathophysiology and clinical implications.

Authors:  Abdulrahman Abutaleb; Sandeep Nathan
Journal:  Interv Neuroradiol       Date:  2021-10       Impact factor: 1.764

2.  NLR value and IL-18 level and their clinical significance in patients with deep vein thrombosis after receiving the surgery for spinal degeneration.

Authors:  Yukun Zhang; Mingyu Cao; Jun Ren
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with cryptogenic stroke in patients with patent foramen ovale.

Authors:  Fatma Nihan Turhan Caglar; Murat Erdem Alp; Nilay Karabulut; Nilgun Isiksacan; Fahrettin Katkat; Hulya Cebe; Ersan Oflar; Didem Melis Oztas; Orhan Rodoplu; Orcun Unal; Cenk Conkbayir; Faruk Akturk; Murat Ugurlucan
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-06-01

4.  C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study.

Authors:  Gro Grimnes; Trond Isaksen; Ynse Ieuwe Gerardus Vladimir Tichelaar; Jan Brox; Sigrid Kufaas Brækkan; John-Bjarne Hansen
Journal:  Haematologica       Date:  2018-04-19       Impact factor: 9.941

5.  Time Course of Inflammatory and Procoagulant Markers in the Early Period After Total Hip Replacement.

Authors:  Peter Poredos; Pavel Poredos; Mateja K Jezovnik; Ana Mavric; Lara Leben; Mojca Bozic Mijovski; Paula Maia; Sandra Haddad; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

6.  Significant decrease in plasmad-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism.

Authors:  Toktam Alirezaei; Haniyeh Sattari; Rana Irilouzadian
Journal:  Clin Cardiol       Date:  2022-04-28       Impact factor: 3.287

7.  Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studies.

Authors:  Søren Beck Jensen; Nadezhda Latysheva; Kristian Hindberg; Thor Ueland
Journal:  J Intern Med       Date:  2022-04-27       Impact factor: 13.068

8.  Hematocrit and incidence of venous thromboembolism.

Authors:  Aaron R Folsom; Wendy Wang; Romil Parikh; Pamela L Lutsey; Joan D Beckman; Mary Cushman
Journal:  Res Pract Thromb Haemost       Date:  2020-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.